Mahmud Kajbaf
Mahmud Kajbaf , PhD
Senior Research Scientist of Drug Metabolism

Division of Aptuit


  • 1984-1988 - Ph.D, King’s College, London, UK
  • PhD in Biopharmacy (Drug Metabolism)
  • 1981-1982 - MSc, Aston University in Birmingham, England, Occupational Health and Safety
  • 1973-1976 - BSc, Institute of Paramedical Sciences, Tehran, Iran, Industrial Hygiene



Dr Mahmud Kajbaf has received his PhD in King’s College, London University during the period of 1984-1988.  Currently, he is working as Senior Scientist at Aptuit Srl. Pharmaceutical Company.His research has included Drug metabolism and mass spectrometry and pharmacokinetics and pharmacodynamics. Based on this research and fellowship training he has received several awards and honors, such as: Aptuit CEO Excellence Award, GlaxoSmithKline the psychiatry CEDD Leadership team Award.He is serving as an editorial member of several reputed journals likeCurrent Drug Metabolism, Drug Metabolism Letters, The Open Drug Metabolism, Open Drug Metabolism Letters, DARU (Journal of Faculty of Pharmacy Tehran University of Medical Sciences), International Biological &Biomedical Journal, Journal of Pharmaceutical Care & Health Systems, : Open Access, Cardiovascular Pharmacology.& expert Reviewers for journals like Journal of Pharmacy and Pharmacology and  Pharmaceutical Sciences, Xenobiotica, Bioanalysis, Clinical Pharmacology and Biopharmaceutics, Journal of  Drug Metabolism and Toxicology, Journal of Developing Drugs, Advances in Pharmacoepidemiology& Drug Safety, Journal of Molecular Biomarkers & Diagnosis, Pharmaceutica Analytica Acta and OMICS Publishing Group. He has authored 31.research articles.


Research Interest

Drug metaboilism, Mass spectrometry, pharmacokinetics and pharmacodynamics

Professional Activities:

26Oct 2010-present Senior Research Scientist Drug Metabolism Division of Aptuit, Verona, Italy
1992–25 Oct 2010 Senior Research Scientist Drug Metabolism Division of Glaxo/GlaxoWellcome/GlaxoSmithKline (Psychiatry /neurosciences CEDD DMPK),Verona, Italy
1989-1992 Research Scientist Medical Research Council (Toxicology Unit).
1987-1988 Postdoctoral Research Fellow King's College


Honors and Awards


  1. Nejla N. Bayraktar, M. Kajbaf, S.D. Jatoe and  J.W. Gorrod (1987): Archiv. Toxicol.;Vol. 60, 91-92.
  2. M. Kajbaf and J.W. Gorrod (1987:). Europ. J. Drug. Met. Pharmacokint.; Vol. 12, No. 4, 285-290.
  3. S.D. Jatoe, M. Kajbaf and J.W. Gorrod (1988): J. Chromatogr.; Vol, 442, 394-400.
  4. C. Ioannides, D.F.V. Lewis, J. Trinick, S. Neville, N.N. Sertkaya, M.Kajbaf and J.W. Gorrod (1989): Vol, 10, No. 8, 1403-1407
  5. M. Kajbaf and J.W.Gorrod (1991): Pharmacology and Clinical Pharmacology; Vol. 8, No. 3, 13-21.
  6. K.Pattichis, M. Kajbaf and J.W. Gorrod (1991): Prog. Pharmacol. and Clin. Pharmacol.;Vol. 8, No. 3, 31-40.
  7. M. Jahanshahi, M. Kajbaf and J.W. Gorrod (1991): Prog. Pharmacol. and Clin. Pharmacol.;Vol. 8, No. 3, 41-48.
  8. M. Kajbaf, K.Pattichis, J. Lamb, J.W. Gorrod and S. Naylor  (1991): Analytica Chimica Acta; Vol. 247, 151-159.
  9. C.K. Tsaprounis, M. Kajbaf and J.W. Gorrod (1991): J. Clin. Hospital. Pharm.: Vol 16,257-262.
  10. M. Kajbaf, M. Jahanshahi, K. Pattichis, J.W. Gorrod and S. Naylor (1992): Sspectrometry. J.Chromatogr.; Vol. 575, 75-85.
  11. S. Naylor,  M. Kajbaf, J.H. Lamb, M. Jahanshahi, and J.W. Gorrod (1992): Biol. Mass Spectrom.; Vol. 21, 165-175
  12. M. Kajbaf, M. Jahanshahi, J. H. Lamb, J.W. Gorrod and S. Naylor  (1992): Xenobiotica.; Vol. 22,No. 6,  641-656.
  13. P.E. Mirkes, N.A. Brown, M. Kajbaf,  J.H. Lamb, P.B. Farmer and S. Naylor (1992): Chem. Res. Toxico.; Vol. 5, 382-385.
  14. J. Fang, J.W. Gorrod, M. Kajbaf,  J.H. Lamb and S. Naylor (1992): Intern. J. Mass spectro. ion proc.; Vol. 122 , 121-131.               
  15. M. Kajbaf, O. Sepai and H. Lamb and S. Naylor (1992): J. Chromatogr. Vol. 583, No.1, 63-76.
  16. S. Naylor, M. Kajbaf, J.H. Lamb, M. Jahanshahi and J.W. Gorrod  (1993): Biol. Mass Spectrom.;  Vol. 22, 388-394
  17. K.Pattichis,  L.L. Louca, M. Kajbaf and J.W.Gorrod (1993):  Med.Sci.Res.; Vol 21, 747-748
  18. M. Ulgen, M. Kajbaf, J.H. Lamb, M. Jahanshahi, J.W Gorrod and S. Naylor (1994): Europ. J. Drug met.Pharmacokinet . Vol 19, No 4, 343-348.
  19. O. Ogunbiyi, M. Kajbaf, J.H. Lamb, M. Jahanshahi, J.W. Gorrod, and S.Naylor (1995): Toxicology Letters  Vol. 78, 25-33.
  20. K. Pattichis, M. Kajbaf and J.W. Gorrod (1997):   Europ. J. Drug met.Pharmacokinet;.Vol. 22, No. 2, 155-164.
  21. M. Kajbaf, P. Rossato, L. Ferrari, P. Grossi and M. Pellegatti (1997): Europ. J. Drug met.Pharmacokinet.; Vol.22, No. 4, 359-366.
  22. M. Kajbaf, P. Rossato, J.R. Barnaby and M. Pellegatti (1998): Xenobiotica; Vol. 28, No. 2, 167-178.
  23. M.Kajbaf, C. Marchioro, J.R. Barnaby and M. Pellegatti (1998): Xenobiotica; Vol. 28, No. 8, 785-794.
  24. R. A.H.J. Gilissen, L. Ferrari,  J.R. Barnaby and M. Kajbaf (2000) Xenobiotica; Vol.30, No. 9, 843-856
  25. R. A.H.J. Gilissen, R. J. Barnaby and M. Kajbaf (2000): Drug Metab.  Drug Interact., Vol 16, No. 3, 173-189.
  26. M. Kajbaf, J.R. Barnaby,  M. Bottacini, L. Bertolotti,  I.M. Ismail, T.J. Cholerton  and M. Pellegatti (2003): Xenobiotica; Vol 33, No. 4, 415-428.
  27. M. Kajbaf,  E Palmieri, R. Longhi,  and S. Fontana (2010): Drug Metab Let, Vol 4, No 2, 104-113.
  28. S. Zambon, S. Fontana and M.Kajbaf  (2010): Drug Metab. Let. Vol 4, No 3, 120-128.
  29. M. Kajbaf,  R. Longhi, D. Montanari,  F.Vinco,  M. Rigo, S. Fontana  and K. Read (2010):Drug Metab. Let.s, Vol 5, No 1, 30-39.
  30. M. Kajbaf, R. Longhi and S. Fontana (2011) Drug Metab Let, Vol 5, No 2, 104-113.
  31. M. Kajbaf, R.  Ricci, S. Zambon  and S. Fontana (2013) Eur. Drug Metab Pharmacokinet. Vol 38, No , 33-41.


Autoimmune Journal Flyer